Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]

Innovations in assessing patient outcomes

Dr Heather Jim - Moffitt Cancer Center, Tampa, USA

Innovations in assessing patient outcomes ( Dr Heather Jim - Moffitt Cancer Center, Tampa, USA )

Repopulation of cancer stem cells in therapeutic resistance

Prof Keith Chan - Baylor College of Medicine, Houston, USA

Repopulation of cancer stem cells in therapeutic resistance ( Prof Keith Chan - Baylor College of Medicine, Houston, USA )

Technologies for personalised cancer immunotherapies

Prof James Heath - California Institute of Technology, Pasadena, USA

Technologies for personalised cancer immunotherapies ( Prof James Heath - California Institute of Technology, Pasadena, USA )

Modulating the DNA damage response: The role of cell cycle checkpoint inhibitors

Dr Shivaani Kummar - Stanford University, Stanford, USA

Modulating the DNA damage response: The role of cell cycle checkpoint inhibitors ( Dr Shivaani Kummar - Stanford University, Stanford, USA )

Comment on RESONATE2 and CLL115 trials

Dr Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK

Comment on RESONATE2 and CLL115 trials ( Dr Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK )

Clinical cases employing novel agents in Hodgkin lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA

Clinical cases employing novel agents in Hodgkin lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA )

Microenvironment of chronic lymphocytic leukaemia

Dr George Follows, Cambridge University Hospitals NHS Foundation Trust...

Microenvironment of chronic lymphocytic leukaemia ( Dr George Follows, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )

Current trials in chronic lymphocytic leukaemia

Dr George Follows - Cambridge University Hospitals NHS Foundation Trust...

Current trials in chronic lymphocytic leukaemia ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )

Chronic lymphocytic leukaemia: Transition to a new era

Prof Stephen Mulligan - Royal North Shore Hospital, Australia

Chronic lymphocytic leukaemia: Transition to a new era ( Prof Stephen Mulligan - Royal North Shore Hospital, Australia )

Ibrutinib as a frontline therapy in RESONATE2 trials for CLL

Prof Jan Burger, MD Anderson Cancer Center, Texas, USA

Ibrutinib as a frontline therapy in RESONATE2 trials for CLL ( Prof Jan Burger, MD Anderson Cancer Center, Texas, USA )

The role of the microenvironment and novel therapies in CLL

Prof Jan Burger - MD Anderson Cancer Center, Texas, USA

The role of the microenvironment and novel therapies in CLL ( Prof Jan Burger - MD Anderson Cancer Center, Texas, USA )

Multi-target S-DNA increases colorectal cancer screening among previously non...

Dr Barry Berger - Exact Sciences, Madison, USA

Multi-target S-DNA increases colorectal cancer screening among previously non-compliant patients ( Dr Barry Berger - Exact Sciences, Madison, USA )

More from ecancer